We are live on
!
Find out more
Aviva Portfolio holdings
AUM
$59.6B
1-Year Est. Return
28.44%
This Fund
S&P 500
This Quarter
Est. Return
+22.86%
1 Year Est. Return
+28.44%
3 Year Est. Return
+95.57%
5 Year Est. Return
+123.24%
10 Year Est. Return
+442.53%
AUM
$16B
AUM Growth
+$2.39B
(+18%)
Cap. Flow
-$371M
Cap. Flow
% of AUM
-2.31%
Top 10 Holdings %
Top 10 Hldgs %
24.43%
Holding
979
New
49
Increased
147
Reduced
723
Closed
36
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Union Pacific
UNP
|
+$101M |
| 2 |
Alcon
ALC
|
+$87.1M |
| 3 |
Otis Worldwide
OTIS
|
+$68.8M |
| 4 |
MRSH
Marsh
MRSH
|
+$50M |
| 5 |
Merck
MRK
|
+$49.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RTN
Raytheon Company
RTN
|
+$56M |
| 2 |
JPMorgan Chase
JPM
|
+$42.7M |
| 3 |
Amazon
AMZN
|
+$38.8M |
| 4 |
AGN
Allergan plc
AGN
|
+$36.5M |
| 5 |
Microsoft
MSFT
|
+$29.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.31% |
| 2 | Healthcare | 14.18% |
| 3 | Financials | 13.68% |
| 4 | Consumer Discretionary | 11.52% |
| 5 | Communication Services | 10.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
576
Vail Resorts
MTN
$5.3B
| $2.46M | 0.02% |
13,513
-592
| -4% | -$104K |
|
577
BorgWarner
BWA
$13.9B
| $2.45M | 0.02% |
78,787
-3,659
| -4% | -$96.4K |
|
578
QuidelOrtho
QDEL
$838M
| $2.43M | 0.02% |
10,854
-27,297
| -72% | -$4.28M |
|
|
EIDX
579
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
| $2.43M | 0.02% |
50,899
-22,207
| -30% | -$1.03M |
|
|
PRNB
580
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
| $2.43M | 0.02% |
40,581
-28,200
| -41% | -$1.74M |
|
581
Perrigo
PRGO
$1.78B
| $2.42M | 0.02% |
43,870
-490
| -1% | -$25.8K |
|
|
SJR
582
DELISTED
Shaw Communications Inc.
SJR
| $2.42M | 0.02% |
149,274
-9,011
| -6% | -$149K |
|
583
Veracyte
VCYT
$3.8B
| $2.42M | 0.02% |
93,409
-66,746
| -42% | -$1.66M |
|
|
WRK
584
DELISTED
WestRock Company
WRK
| $2.42M | 0.02% |
85,488
-3,796
| -4% | -$108K |
|
585
10x Genomics
TXG
$6.61B
| $2.41M | 0.02% |
+26,979
| New | +$2.1M |
|
586
Lincoln National
LNC
$8.81B
| $2.4M | 0.02% |
65,362
-4,361
| -6% | -$153K |
|
|
VVNT
587
DELISTED
Vivint Smart Home, Inc. Class A Common Stock
VVNT
| $2.4M | 0.02% |
+138,752
| New | +$1.74M |
|
588
AGNC Investment
AGNC
$12.9B
| $2.4M | 0.02% |
186,025
-4,145
| -2% | -$52K |
|
|
LVGO
589
DELISTED
Livongo Health, Inc. Common Stock
LVGO
| $2.4M | 0.02% |
+31,916
| New | +$1.67M |
|
590
Coca-Cola Europacific Partners
CCEP
$47.9B
| $2.39M | 0.01% |
63,256
+1,498
| +2% | +$58.8K |
|
591
CryoPort
CYRX
$762M
| $2.39M | 0.01% |
78,944
-149,615
| -65% | -$3.33M |
|
592
Bio-Rad Laboratories Class A
BIO
$9.42B
| $2.38M | 0.01% |
5,282
-5,534
| -51% | -$2.44M |
|
593
Exelixis
EXEL
$13.4B
| $2.38M | 0.01% |
100,478
-110,340
| -52% | -$2.56M |
|
594
NovaGold Resources
NG
$3.33B
| $2.38M | 0.01% |
259,234
-199,976
| -44% | -$2.03M |
|
595
Bio-Techne
TECH
$11.3B
| $2.38M | 0.01% |
35,988
-43,040
| -54% | -$2.58M |
|
596
Insulet
PODD
$9.79B
| $2.37M | 0.01% |
12,214
-8,679
| -42% | -$1.66M |
|
597
Zscaler
ZS
$27.3B
| $2.37M | 0.01% |
21,672
-39,956
| -65% | -$3.32M |
|
598
Datadog
DDOG
$84B
| $2.37M | 0.01% |
+27,279
| New | +$1.66M |
|
599
Halozyme
HALO
$12.2B
| $2.37M | 0.01% |
88,453
-114,004
| -56% | -$2.57M |
|
|
MASI
600
DELISTED
Masimo
MASI
| $2.37M | 0.01% |
10,394
-9,846
| -49% | -$2.16M |
|
Similar funds
QCM
NAMI
Aviva's Q2 2020 Portfolio in Review
As of Q2 2020, Aviva held 979 positions worth $16B, up 18% from $13.7B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Aviva's Q2 2020 filing shows 49 new, 147 increased, 723 reduced and 36 closed positions. Its largest new stake was Otis Worldwide: 1,327,192 shares worth $75.5M. The largest sale was Raytheon Company, an estimated $56M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
- Aviva's largest Q2 2020 buy was Otis Worldwide: 1,327,192 shares worth $75.5M.
- Aviva added most to Union Pacific in Q2 2020, an estimated $101M increase.
- Aviva's biggest Q2 2020 reduction was JPMorgan Chase, cutting an estimated $42.7M.
- Aviva fully exited Raytheon Company in Q2 2020, selling an estimated $56M.
- Aviva's ten largest holdings make up 24% of its $16B portfolio in Q2 2020.
- Aviva opened 49 new positions and closed 36 in Q2 2020.
- Aviva's portfolio value rose 18% quarter-over-quarter to $16B.
Based on Aviva's 13F filing for Q2 2020, filed 13 Aug 2020.